BMO Capital downgraded Alexandria Real Estate (ARE) to Market Perform from Outperform with a price target of $52, down from $65. The firm cites elevated dilution from the company’s asset sales and increased uncertainty on a demand recovery in life sciences for the downgrade. Alexandria’s asset sales are being overshadowed by higher interest rates and the “looming AI-threat” on lab office demand, the analyst tells investors in a research note. BMO favors companies with “solid earnings growth,” which it says is unlikely for Alexandria.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARE:
- Alexandria Real Estate price target lowered to $57 from $63 at JPMorgan
- Alexandria Equities Reports New Direct Financial Obligation
- Alexandria Equities Prices $750 Million Senior Notes Offering
- Alexandria Real Estate price target lowered to $54 from $55 at Morgan Stanley
- Neutral on Alexandria Real Estate: Strong Life Science Portfolio but Limited Near-Term Upside Amid Slow Lab-Space Recovery
